Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Details for Australian Patent Application No. 2005266461 (hide)

Owner Aventis Pharma S.A.

Inventors Malleron, Jean-Luc; Ritter, Kurt; Guessregen, Stefan; Ruf, Sven; Lebrun, Anne; Lesuisse, Dominique; Nemecek, Conception; Strobel, Hartmut

Agent A J Park

Pub. Number AU-A-2005266461

PCT Pub. Number WO2006/010642

Priority 04291905.0 27.07.04 EP

Filing date 25 July 2005

Wipo publication date 2 February 2006

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4178 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/010642 Priority application(s): WO2006/010642

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266462-Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

2005266460-Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors